Antiandrogen Withdrawal Syndrome With Nilutamide

No AccessJournal of UrologyClinical Urology: Case Report1 Apr 1997Antiandrogen Withdrawal Syndrome With Nilutamide Leonard G. Gomella, Mohamed Ismail, and Faith E. Nathan Leonard G. GomellaLeonard G. Gomella , Mohamed IsmailMohamed Ismail , and Faith E. NathanFaith E. Nathan View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)64984-XAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Antiandrogen Withdrawal Syndrome With Nilutamide." The Journal of Urology, 157(4), p. 1366 References 1 : Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer. Urology1996; 47: 61. Google Scholar 2 : Focus on nilutamide: a non-steroidal antiandrogen for the treatment of advanced prostate cancer. Formulary1996; 31: 105. Google Scholar 3 : Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal. J. Urol.1996; 155: 620. Link, Google Scholar From the Department of Urology and Division of Neoplastic Disease, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania© 1997 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 157Issue 4April 1997Page: 1366 Advertisement Copyright & Permissions© 1997 by American Urological Association, Inc.MetricsAuthor Information Leonard G. Gomella More articles by this author Mohamed Ismail More articles by this author Faith E. Nathan More articles by this author Expand All Advertisement PDF downloadLoading ...